Fetal and Neonatal Alloimmune Thrombocytopenia—New Prospects for Fetal Risk Assessment of HPA-1a–Negative Pregnant Women
Open Access
- 1 October 2020
- journal article
- review article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 34 (4) , 270-276
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic reviewBJOG: An International Journal of Obstetrics & Gynaecology, 2010
- Fetal Brain Vascularity Visualized by Conventional 2D and 3D Power Doppler TechnologyDonald School Journal of Ultrasound in Obstetrics and Gynecology, 2010
- Naturally processed peptides spanning the HPA-1a polymorphism are efficiently generated and displayed from platelet glycoprotein by HLA-DRB3*0101–positive antigen-presenting cellsBlood, 2009
- HPA-1a alloantibodies reduce endothelial cell spreading and monolayer integrityMolecular Immunology, 2009
- Crystallographic Structure of the Human Leukocyte Antigen DRA, DRB3*0101: Models of a Directional Alloimmune Response and AutoimmunityJournal of Molecular Biology, 2007
- Quantification of human platelet antigen‐1a antibodies with the monoclonal antibody immobilization of platelet antigens procedureTransfusion, 2005
- Functional heterogeneity of alloantibodies against the human platelet antigen (HPA)-1aThrombosis and Haemostasis, 2005
- Survey of the use and clinical effectiveness of HPA-1a/5b-negative platelet concentrates in proven or suspected platelet alloimmunizationTransfusion Medicine, 2004
- Susceptibility to alloimmunization to platelet HPA-la antigen involves TAP1 polymorphismHuman Immunology, 1994
- HLA-DRw52a is involved in alloimmunization against PL-A1 antigenHuman Immunology, 1990